, a bio/informatics shared resource is still "open for business" - Visit the CDS website

  1. Examining the role of CD1d and natural killer T cells in the development of nephritis in a genetically susceptible lupus model. Yang JQ, Wen X, Liu H, Folayan G, Dong X, Zhou M, Van Kaer L, Singh RR (2007) Arthritis Rheum 56(4): 1219-33
    › Primary publication · 17393451 (PubMed) · PMC2291538 (PubMed Central)
  2. Assessing the role of immuno-proteasomes in a mouse model of familial ALS. Puttaparthi K, Van Kaer L, Elliott JL (2007) Exp Neurol 206(1): 53-8
    › Primary publication · 17482163 (PubMed) · PMC2692686 (PubMed Central)
  3. Viral evasion of antigen presentation: not just for peptides anymore. Van Kaer L, Joyce S (2006) Nat Immunol 7(8): 795-7
    › Primary publication · 16855602 (PubMed)
  4. The role of invariant natural killer T cells in lupus and atherogenesis. Major AS, Singh RR, Joyce S, Van Kaer L (2006) Immunol Res 34(1): 49-66
    › Primary publication · 16720898 (PubMed) · PMC2291524 (PubMed Central)
  5. Role of invariant natural killer T cells in immune regulation and as potential therapeutic targets in autoimmune disease. Van Kaer L (2006) Expert Rev Clin Immunol 2(5): 745-57
    › Primary publication · 20477630 (PubMed)
  6. Reciprocal regulation between natural killer cells and autoreactive T cells. Shi FD, Van Kaer L (2006) Nat Rev Immunol 6(10): 751-60
    › Primary publication · 16998508 (PubMed)
  7. Pivotal roles of CD8+ T cells restricted by MHC class I-like molecules in autoimmune diseases. Das G, Das J, Eynott P, Zhang Y, Bothwell AL, Van Kaer L, Shi Y (2006) J Exp Med 203(12): 2603-11
    › Primary publication · 17088432 (PubMed) · PMC2118151 (PubMed Central)
  8. Natural killer T cells and CD8+ T cells are dispensable for T cell-dependent allergic airway inflammation. Das J, Eynott P, Jupp R, Bothwell A, Van Kaer L, Shi Y, Das G (2006) Nat Med 12(12): 1345-6; author reply 1347
    › Primary publication · 17151684 (PubMed)
  9. Natural killer T cells ameliorate antibody-induced arthritis in macrophage migration inhibitory factor transgenic mice. Takagi D, Iwabuchi K, Maeda M, Nakamaru Y, Furuta Y, Fukuda S, Van Kaer L, Nishihira J, OnoƩ K (2006) Int J Mol Med 18(5): 829-36
    › Primary publication · 17016612 (PubMed)
  10. Lipid metabolism, atherogenesis and CD1-restricted antigen presentation. Major AS, Joyce S, Van Kaer L (2006) Trends Mol Med 12(6): 270-8
    › Primary publication · 16651026 (PubMed)